Teva Pharmaceutical Industries Limited's total liabilities is $32B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Teva Pharmaceutical Industries Limited's total liabilities stands at $32B as of September 2026. That compares with $21B in the prior-year period — up 51.8% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Teva Pharmaceutical Industries Limited reported $32B in total liabilities versus $21B a year earlier — a 51.8% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.
That compares with $21B in the prior-year period — up 51.8% year over year. Sustained growth in total liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.
The history chart shows how Teva Pharmaceutical Industries Limited's total liabilities evolved across reporting periods, while the comparison chart places TEVJF next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Healthcare, total liabilities is commonly used to spot outliers. Teva Pharmaceutical Industries Limited's reading of $32B is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.